Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Correlation between Self-reported Paracetamol Dose and Hepatotoxicity
TCTR20251221001Recruiting
- Sponsor
- Phrapokklao Research Center
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of acetaminophen in pain, fever and Drug-induced hepatitis (DILI), sponsored by Phrapokklao Research Center. Primary endpoint: Association between self-reported paracetamol dose and hepatotoxicity. Started Dec 2019; status: recruiting.
02
Drugs
acetaminophen
03
Conditions
painfeverDrug-induced hepatitis (DILI)
Beyond the preview
Go deeper on TCTR20251221001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251221001.